Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    Who should be taking aspirin to prevent coronary events?
    Michael S. Lauer, MD
    Cleveland Clinic Journal of Medicine December 2003, 70 (12) 1076-1080;

    How to use the estimated coronary risk in deciding whether to prescribe long-term aspirin therapy, with an algorithm and three brief examples.

  • You have access
    Age-related macular degeneration: Evaluation and treatment
    Darius M. Moshfeghi, MD and Hilel Lewis, MD
    Cleveland Clinic Journal of Medicine December 2003, 70 (12) 1017-1037;

    Any patient age 50 or older with vision loss or distorted vision deserves an immediate referral to an ophthalmologist. Hypertension control and smoking cessation are important.

  • You have access
    Up pops the devil
    John D. Clough, MD
    Cleveland Clinic Journal of Medicine December 2003, 70 (12) 1007;

    The COMET trial is important for the treatment of heart failure, but the devil is in the details.

  • You have access
    Scleroderma: A treatable disease
    Joseph H. Korn, MD
    Cleveland Clinic Journal of Medicine November 2003, 70 (11) 954-968;

    Scleroderma can be effectively treated in many cases now, thanks to a better understanding of its pathogenesis and new therapies.

  • Straight talk about St. John’s wort
    You have access
    Straight talk about St. John’s wort
    Cleveland Clinic Journal of Medicine November 2003, 70 (11) 990;
  • You have access
    The Heart Protection Study: High-risk patients benefit from statins, regardless of LDL-C level
    Hitinder S. Gurm, MBBS and Byron Hoogwerf, MD
    Cleveland Clinic Journal of Medicine November 2003, 70 (11) 991-997;

    Nearly all patients at high risk of a coronary event should be taking a statin drug, regardless of their low-density lipoprotein level. We explain the rationale, design, findings, and implications of this important study.

  • You have access
    Alcohol and health: A drink a day won’t keep the doctor away
    Charles S. Lieber, MD
    Cleveland Clinic Journal of Medicine November 2003, 70 (11) 945-953;

    Do not advise patients to start drinking alcohol for its alleged cardiovascular benefits.

  • You have access
    Extraesophageal symptoms of GERD
    Kenneth R. DeVault, MD
    Cleveland Clinic Journal of Medicine November 2003, 70 (11 suppl 5) S20-S32;
  • You have access
    GERD pathogenesis, pathophysiology, and clinical manifestations
    Peter J. Kahrilas, MD
    Cleveland Clinic Journal of Medicine November 2003, 70 (11 suppl 5) S4-S19;
  • You have access
    Profile and assessment of GERD pharmacotherapy
    Paul N. Maton, MD
    Cleveland Clinic Journal of Medicine November 2003, 70 (11 suppl 5) S51-S70;

Pages

  • Previous
  • Next
  • 1
  • …
  • 358
  • 359
  • 360
  • 361
  • 362
  • 363
  • 364
  • 365
  • 366
  • …
  • 799

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire